RARS1 and metabolic dysfunction-associated steatotic liver disease: RA and RARs regulate a number of pathways implicated in obesity-related disorders such as type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD) [4, 16, 17].